Llibre RJ, Gutiérrez HRF

Language: Spanish
References: 24
Page: 378-387
PDF size: 200.83 Kb.

ABSTRACT

Although dementia is the leading cause of disability and the main causative factor of dependence in the elderly, and of economic burden and psychological stress in the caregiver, it has not yet been prioritized in the same degree as other noncommunicable chronic diseases, such as cardiovascular disease and cancer, which have a greater impact on mortality. Some aspects related to the prevalence and the rise of number of people with dementia in Latin America and the Caribbean for 2030 were discussed in this paper. The impact of dementia as well as the knowledge about and control of its risk factors were also addressed, using perspective course of life from the conception and intrauterine life to the late age and the multifactoral approach, all of which could potentially lead to a reduction in the number of patients with dementia. Greater emphasis on prevention, broad access to education, better socioeconomic conditions, healthy lifestyles and control of cardiovascular risk factors to reduce the growing impact of dementia in the society are sustainable viable alternatives for the reduction of growing impact of dementias on the society.

REFERENCES

1. World Health Organization. Dementia: A public health priority. Geneva: WHO; 2012 [cited 2012 Jun 5] Available from: http://www.who.int/mental_health/publications/dementia_report_2012

2. Sousa RM, Ferri CP, Acosta D, Albanese E, Guerra M, Huang Y, et al. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet. 2009;374(9704):1821-30.

3. Prince M, Guerchet M, Prina M. Policy Brief for Heads of Government: The Global Impact of Dementia 20132050. London: Alzheimer's Disease International (ADI); 2013 [cited 2013 Dec 20]. Available from: http://www.alz.co.uk/research/GlobalImpactDementia2013.pdf

4. Prince M, Acosta D, Ferri CP, Guerra M, Huang Y, Llibre Rodriguez JJ, et al. Dementia incidence and mortality in middle income countries, and associations with age, sex, socioeconomic position and indicators of cognitive reserve. A 10/66 Dementia Research Group population-based cohort study . Lancet. 2012;380 (9836):50-8. EPub 2012 May 23. doi:10.1016/S0140-6736(12)60399-7

5. Llibre Rodriguez JJ, Ferri CP, Acosta D, Guerra M, Martin P. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet. 2008;372: 46474. EPub 2008 July 28. doi: 10.1016/S0140- 6736(08)61002-8

6. Sousa RM, Ferri CP, Acosta D, Guerra M, Huang Y, Ks J, et al. The contribution of chronic diseases to the prevalence of dependence among older people in Latin America, China and India: a 10/66 Dementia Research Group population-based survey. BMC Geriatr. 2010;10(1):53.

7. Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M, et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet. 2008;372(9642):940-9.

8. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C. Life course epidemiology. J Epidemiol Comm Health. 2003;57:778-83. PubMed: 14573579.

9. Hughes T, Ganguli M. Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev. 2009;5(2):7392.

10. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7:137-52. Epub 2011 Feb 8. doi:10.1038/nrneurol.2011.2

11. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377:101931.

12. Lee Y, Back JH, Kim J. Systematic review of health behavioural risks and cognitive health in older adults. Int Psychogeriatr. 2010;22:17487.

13. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819-28.

14. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63:530-38.

15. Farlow MR. Alzheimer's disease. Continuum Lifelong Learning Neurol. 2007;13(2):3968.

16. Manton KC, Gu XL, Ukraintseva SV. Declining prevalence of dementia in the U.S. elderly population. Adv Gerontol. 2005;16:30-7.

17. Langa KM, Larson EB, Karlawish JH. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement. 2008;4:134-44.

18. Schrijvers EMC, Verhaaren BFJ, Koudstaal PJ, Hofman A, Ikram MA, Breteler MMB. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78:1456-63.

19. Qiu C, von Strauss E, Bäckman L, Winblad B, Fratiglioni L. Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology. 2013;80:1888-94.

20. Matthews FE, Arthur A, Barnes LE. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382:1405-12.

21. Larson EB, Yaffe K, Langa K. Perspective. New Insights into the Dementia Epidemic. New Engl J Med. 2013;369(24):2275-7. Epub 2013 Nov 27. doi:10.1056/NEJMp1311405

22. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization [review]. Circulation. 2001;104(22):2746-53.

23. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;1:CD005593.

24. Reisberg B, Doody R, Stoffler A. Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003;348:1333-41.